Number (%) of patients with response during protocol treatment
| . | Arm A: VAD n = 268 (%) . | Arm B: TAD n = 268 (%) . | P . |
|---|---|---|---|
| Response on VAD/TAD | |||
| At least PR | 153 (57) | 189 (71) | .001 |
| At least VGPR | 49 (18) | 98 (37) | < .001 |
| CR | 6 (2) | 9 (3) | .43 |
| Response on VAD/TAD and HDM | |||
| At least PR | 204 (76) | 225 (84) | .02 |
| At least VGPR | 119 (44) | 145 (54) | .03 |
| CR | 31 (12) | 37 (14) | .44 |
| Response on protocol treatment | |||
| At least PR | 211 (79%) | 235 (88%) | .005 |
| At least VGPR | 144 (54%) | 176 (66%) | .005 |
| CR | 61 (23%) | 82 (31%) | .04 |
| . | Arm A: VAD n = 268 (%) . | Arm B: TAD n = 268 (%) . | P . |
|---|---|---|---|
| Response on VAD/TAD | |||
| At least PR | 153 (57) | 189 (71) | .001 |
| At least VGPR | 49 (18) | 98 (37) | < .001 |
| CR | 6 (2) | 9 (3) | .43 |
| Response on VAD/TAD and HDM | |||
| At least PR | 204 (76) | 225 (84) | .02 |
| At least VGPR | 119 (44) | 145 (54) | .03 |
| CR | 31 (12) | 37 (14) | .44 |
| Response on protocol treatment | |||
| At least PR | 211 (79%) | 235 (88%) | .005 |
| At least VGPR | 144 (54%) | 176 (66%) | .005 |
| CR | 61 (23%) | 82 (31%) | .04 |
VAD indicates vincristine, adriamycin, and dexamethasone; TAD, thalidomide, adriamycin, and dexamethasone; PR, partial remission; VGPR, very good partial remission; and CR, complete remission.